28.2.2022
•
News
KSB scores in Chambers Global 2022
The renowned British rating agency Chambers and Partners once again recommends Kocián Šolc Balaštík in its current publication “Chambers Global 2022”.
KŠB succeeded again in all categories evaluated in the global yearbook, namely:
- Banking & Finance
- Capital Markets
- Corporate and M&A
- Dispute Resolution
Dagmar Dubecká and Martin Šolc (category Mergers / Acquisitions and Corporate Law), Pavel Dejl (Dispute Resolution), Martin Krejčí (Banking & Finance) and Vlastimil Pihera (Capital Markets) are also recommended in the new yearbook.
We greatly appreciate being ranked again in all these categories, which proves the continued quality of our legal services. We would also like to thank our clients; without whose support and satisfaction we would not have received this privilege.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
